AbstractThe human folate receptor (FR) is overexpressed in ovarian carcinoma. FR transcripts are heterogeneous due to the use of two promoters, P1 and P4, and alternative splicing of exon 3. RNase protection assay and RT-PCR revealed higher levels of the transcripts that include exon 3 in lines and specimens from ovarian carcinoma. A P1–chloramphenicol acetyltransferase (CAT) construct containing exon 3 demonstrated efficient reporter expression only in ovarian carcinoma. 5′ and 3′ deleted variants of the P1–CAT construct were analyzed by RT-PCR of the exogenous transcripts and reporter activity. A 5′ splice site and 35 bp downstream intronic region of exon 3 appeared to regulate enhanced FR expression in ovarian carcinoma
The folate receptor (FR) is expressed in a variety of gynecological cancer types. It has been widely...
<div><p>Folate receptor alpha (FOLR1) has been identified as a potential prognostic and therapeutic ...
Folate can be transported into the cell by the reduced folate carrier (RFC), the proton-coupled fola...
Ovarian cancer is a common gynecological cancer world-wide and contributes to the highest mortality ...
Despite being an essential vitamin, folate has been implicated to enhance tumor growth, as evidenced...
Despite being an essential vitamin, folate has been implicated to enhance tumor growth, as evidenced...
Ovarian cancer is the most frequent cause of gynecological cancer-related death. Unfortunately, many...
Folate receptor alpha (FOLR1/FRA) is reported to be overexpressed in epithelial ovarian cancers (EOC...
Despite being an essential vitamin, folate has been implicated to enhance tumor growth, as evidenced...
Despite low incidence, ovarian cancer is the fifth leading cause of cancer deaths and it has the hig...
The primary structures of the human KB cell (FR-KB1) folate receptor (FR) and of a human placental (...
Tumor-specific targeted imaging is rapidly evolving in cancer diagnosis. The folate receptor alpha (...
Folate receptor alpha (FOLR1) has been identified as a potential prognostic and therapeutic target i...
The alpha-folate receptor (alpha-FR) is highly-expressed in various non-mucinous tumors of epithelia...
The folate receptor (FR) is expressed in a variety of gynecological cancer types. It has been widely...
The folate receptor (FR) is expressed in a variety of gynecological cancer types. It has been widely...
<div><p>Folate receptor alpha (FOLR1) has been identified as a potential prognostic and therapeutic ...
Folate can be transported into the cell by the reduced folate carrier (RFC), the proton-coupled fola...
Ovarian cancer is a common gynecological cancer world-wide and contributes to the highest mortality ...
Despite being an essential vitamin, folate has been implicated to enhance tumor growth, as evidenced...
Despite being an essential vitamin, folate has been implicated to enhance tumor growth, as evidenced...
Ovarian cancer is the most frequent cause of gynecological cancer-related death. Unfortunately, many...
Folate receptor alpha (FOLR1/FRA) is reported to be overexpressed in epithelial ovarian cancers (EOC...
Despite being an essential vitamin, folate has been implicated to enhance tumor growth, as evidenced...
Despite low incidence, ovarian cancer is the fifth leading cause of cancer deaths and it has the hig...
The primary structures of the human KB cell (FR-KB1) folate receptor (FR) and of a human placental (...
Tumor-specific targeted imaging is rapidly evolving in cancer diagnosis. The folate receptor alpha (...
Folate receptor alpha (FOLR1) has been identified as a potential prognostic and therapeutic target i...
The alpha-folate receptor (alpha-FR) is highly-expressed in various non-mucinous tumors of epithelia...
The folate receptor (FR) is expressed in a variety of gynecological cancer types. It has been widely...
The folate receptor (FR) is expressed in a variety of gynecological cancer types. It has been widely...
<div><p>Folate receptor alpha (FOLR1) has been identified as a potential prognostic and therapeutic ...
Folate can be transported into the cell by the reduced folate carrier (RFC), the proton-coupled fola...